Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00XZH
|
||||
| Former ID |
DNC007718
|
||||
| Drug Name |
1-benzhydryl-4-isopropylpiperidin-4-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528781] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H27NO
|
||||
| Canonical SMILES |
CC(C)C1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)O
|
||||
| InChI |
1S/C21H27NO/c1-17(2)21(23)13-15-22(16-14-21)20(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,17,20,23H,13-16H2,1-2H3
|
||||
| InChIKey |
BOIJUJOJZXIYHU-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Nociceptin receptor | Target Info | Inhibitor | [528781] | |
| Mu-type opioid receptor | Target Info | Inhibitor | [528781] | ||
| Kappa-type opioid receptor | Target Info | Inhibitor | [528781] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.